PeptiMimesis Overview
- Founded
-
2015
- Status
-
Private
- Latest Deal Type
-
Angel
- Latest Deal Amount
-
$323K
- Investors
-
2
PeptiMimesis General Information
Description
Developer of transmembrane therapeutic peptides designed to identify peptidomimetic candidates suffering from hetero. The company develops its pipeline against key targets in the fields of oncology and immuno-oncology and is open to initiating collaboration with pharma partners on receptors of interest, enabling professionals to identify peptidomimetic candidates interfering with the hetero and/or the homodimerization of target receptors.
Contact Information
Website
www.peptimimesis.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 850 Boulevard Sébastien Brant
- 67400 Illkirch
- France
PeptiMimesis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Angel (individual) | 31-Mar-2020 | $323K | 00.000 | 00.000 | Completed | Generating Revenue |
| 1. Seed Round | 15-Mar-2017 | 00.000 | 00.000 | 00.000 | Completed | Generating Revenue |
PeptiMimesis Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 0,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
| Ordinary | 0,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.00 | |
| A shares | 7,143 | $1.107247 | $77.51 | $77.51 | 1x | $77.51 | 16.24% |
PeptiMimesis Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Marjorie Sidhoum Ph.D | President | ||
| Gerard Cremel | Co-Founder & Founding Member | ||
| Dominique Bagnard Ph.D | Co-Founder | ||
| Pascal Neuville | Co-Founder |
PeptiMimesis Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Capital Grand Est | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Domain Therapeutics | VC-Backed Company | Minority | 000 0000 | 000000 0 |
PeptiMimesis Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000 00000000 | 08-Jun-2020 | 00000 0000 | Drug Discovery | 00000000 |